ArticleAdvances in therapy2016

Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials.

Francesco Locatelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.